Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy
- 30 April 2009
- journal article
- Published by Elsevier BV in Urology
- Vol. 73 (4), 833-837
- https://doi.org/10.1016/j.urology.2008.09.036
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- RTOG 97-06: Initial report of a Phase I–II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Organ Conservation in Invasive Bladder Cancer by Transurethral Resection, Chemotherapy and Radiation: Results of a Urodynamic and Quality of Life Study on Long-term SurvivorsJournal of Urology, 2003
- Combined-Modality Treatment and Selective Organ Preservation in Invasive Bladder Cancer: Long-Term ResultsJournal of Clinical Oncology, 2002
- Gemcitabine-induced radiation recallInternational Journal of Radiation Oncology*Biology*Physics, 2002
- The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial ResponseThe Oncologist, 2000
- Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyJournal of Clinical Oncology, 2000
- Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Metastatic Urothelial CancerJournal of Clinical Oncology, 2000
- Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.Journal of Clinical Oncology, 1998
- Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of rtog protocol 85-12International Journal of Radiation Oncology*Biology*Physics, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958